Study of a semaglutide implant for weight management
Part of Hormones & metabolism clinical trials.
This early-stage study tests a small implant placed under the skin that releases a weight management medicine (semaglutide) slowly over time. The goal is to see how safe it is and how your body handles it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your body mass index (BMI) must be between 27 and 40.
- You must not have diabetes (either type 1 or type 2).
- You must not have taken any blood sugar-lowering medicines in the last 3 months.
- You must be generally healthy, with no major health problems that could make the study risky for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a plant-based supplement (called 20E) to the weight-loss medication semaglutide can improve weight loss and muscle health. You would take the supplement as capsules alongside your regular semaglutide treatment.
This study tests a weekly injection called semaglutide to see how well it helps people with obesity lose weight, compared to a similar approved medicine, Wegovy. It may be an option if you have struggled to lose weight in the past.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This study tests a new weekly injection (called NNC0487-0111) against an existing medicine (semaglutide) to see if it helps people with type 2 diabetes lose more weight. Together with standard diabetes care and lifestyle changes, you would receive the study medicine for about a year, and the study team will monitor your health and weight.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
This study tests whether semaglutide, a medicine that helps control blood sugar and reduce weight, can benefit adults with type 1 diabetes who are overweight. If you qualify, you may receive the drug or a placebo, and the study team will monitor your health closely.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.